Development of geriatric oncology in Latin America: A report from the Latin American Cooperative Oncology Group.

Autor: de Barros LPL; Oncology and Hematology Department, HCor, São Paulo, Brazil; Latin American Cooperative Oncology Group (LACOG), Porto Alegre, Brazil. Electronic address: luciolaplbarros@gmail.com., de Oliveira Muniz Koch L; Latin American Cooperative Oncology Group (LACOG), Porto Alegre, Brazil; Oncology and Hematology Department, Hospital Israelita Albert Einstein, São Paulo, Brazil., de Oliveira Lima JT; IMIP - Instituto Medicina Integral Prof. Fernando Figueira, Recife, Brazil., Apolinario TL; IMIP - Instituto Medicina Integral Prof. Fernando Figueira, Recife, Brazil., Dettino ALA; A. C. Camargo Cancer Center, São Paulo, Brazil., Petrarca CR; Hospital FAU-UFPel, Pelotas, Brazil., Martins JC; Prevent Senior, São Paulo, Brazil., de Souza PMR; Hospital Israelita Albert Einstein, São Paulo, Brazil., Rodrigues M; Hospital Israelita Albert Einstein, São Paulo, Brazil., de Souza E Silva JT; Oncologia D'or, Brasília, Brazil., Karnakis T; Cancer Institute of São Paulo, University of São Paulo, São Paulo, Brazil., Junior LAG; Geriatric Center for Advanced Medicine, Hospital Sirio-Libanês, São Paulo, SP, Brazil., Junior MGA; Prevent Senior, São Paulo, Brazil., Honorato M; Department of Geriatrics, Clínica Alemana de Santiago, Santiago, Chile., Abalos VR; Department of Geriatrics, Clínica Alemana de Santiago, Santiago, Chile., Alvarado OC; Department of Geriatrics, Clínica Alemana de Santiago, Santiago, Chile; Complejo Asistencial Dr. Sótero del Río, Santiago, Chile., Navarrete G; Hospital Clínico Universidad de Chile, Santiago, Chile; Fundación Arturo Lopez Perez, Santiago, Chile., Rebelatto TF; Latin American Cooperative Oncology Group (LACOG), Porto Alegre, Brazil., Soto-Perez-de-Celis E; Department of Geriatrics, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, México City, Mexico.

Publikováno v: Journal of geriatric oncology [J Geriatr Oncol] 2024 Apr; Vol. 15 (3), pp. 101642. Date of Electronic Publication: 2023 Nov 15.

Navigating 'grey areas' and challenges during evaluation of transplant eligibility in specific myelofibrosis populations: a perspective on behalf of the Chronic Malignancies Working Party of the EBMT.

Autor: Polverelli N; Unit of Bone Marrow Transplantation and Cellular Therapies - Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy. n.polverelli@smatteo.pv.it., Hernández-Boluda JC; Department of Hematology, Hospital Clínico Universitario, Valencia, Spain., Gagelmann N; Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Gurnari C; Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy.; Translational Hematology and Oncology Research Department, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH, USA., Malagola M; Chair of Hematology, Department of Clinical and Experimental Sciences, University of Brescia, Unit of Blood Disease and Stem Cell Transplantation, ASST Spedali Civili, Brescia, Italy., Duarte FB; Hospital Universitario Walter Cantídio, Universidade Federal do Ceara, Fortaleza, Brazil., Funke VAM; Blood and Marrow Transplantation Programme, Hospital de Clínicas, Federal University of Parana, Curitiba, Paraná, Brazil.; Hospital Nossa Senhora das Graças, Curitiba, Brazil., Zerbi C; Unit of Bone Marrow Transplantation and Cellular Therapies - Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy., McLornan DP; Department of Haematology and Stem Cell transplantation, University College London Hospitals NHS Foundation Trust, London, UK. donal.mclornan@nhs.net.

Publikováno v: Bone marrow transplantation [Bone Marrow Transplant] 2024 Oct 14. Date of Electronic Publication: 2024 Oct 14.

Age barriers in allogeneic hematopoietic cell transplantation: Raising the silver curtain.

Autor: Munshi PN; Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine of the University of Pennsylvania, Philadelphia, Pennsylvania, USA., McCurdy SR; Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine of the University of Pennsylvania, Philadelphia, Pennsylvania, USA.

Publikováno v: American journal of hematology [Am J Hematol] 2024 May; Vol. 99 (5), pp. 922-937. Date of Electronic Publication: 2024 Feb 27.

HCT frailty scale for younger and older adults undergoing allogeneic hematopoietic cell transplantation.

Autor: Salas MQ; Department of Medicine, Section of Medical Oncology and Hematology, University of Toronto, Toronto, ON, Canada.; Hans Messner Allogeneic Blood and Marrow Transplantation Program, Division of Medical Oncology and Hematology. Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.; HCT Unit, Hospital Clinic de Barcelona, ICHMO, Barcelona, Spain., Atenafu EG; Department of Biostatistics, Princes Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Pasic I; Department of Medicine, Section of Medical Oncology and Hematology, University of Toronto, Toronto, ON, Canada.; Hans Messner Allogeneic Blood and Marrow Transplantation Program, Division of Medical Oncology and Hematology. Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Bascom O; Hans Messner Allogeneic Blood and Marrow Transplantation Program, Division of Medical Oncology and Hematology. Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Wilson L; Hans Messner Allogeneic Blood and Marrow Transplantation Program, Division of Medical Oncology and Hematology. Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Lam W; Department of Medicine, Section of Medical Oncology and Hematology, University of Toronto, Toronto, ON, Canada.; Hans Messner Allogeneic Blood and Marrow Transplantation Program, Division of Medical Oncology and Hematology. Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Law AD; Department of Medicine, Section of Medical Oncology and Hematology, University of Toronto, Toronto, ON, Canada.; Hans Messner Allogeneic Blood and Marrow Transplantation Program, Division of Medical Oncology and Hematology. Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Chen C; Department of Medicine, Section of Medical Oncology and Hematology, University of Toronto, Toronto, ON, Canada.; Hans Messner Allogeneic Blood and Marrow Transplantation Program, Division of Medical Oncology and Hematology. Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Novitzky-Basso I; Department of Medicine, Section of Medical Oncology and Hematology, University of Toronto, Toronto, ON, Canada.; Hans Messner Allogeneic Blood and Marrow Transplantation Program, Division of Medical Oncology and Hematology. Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Kim DDH; Department of Medicine, Section of Medical Oncology and Hematology, University of Toronto, Toronto, ON, Canada.; Hans Messner Allogeneic Blood and Marrow Transplantation Program, Division of Medical Oncology and Hematology. Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Gerbitz A; Department of Medicine, Section of Medical Oncology and Hematology, University of Toronto, Toronto, ON, Canada.; Hans Messner Allogeneic Blood and Marrow Transplantation Program, Division of Medical Oncology and Hematology. Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Viswabandya A; Department of Medicine, Section of Medical Oncology and Hematology, University of Toronto, Toronto, ON, Canada.; Hans Messner Allogeneic Blood and Marrow Transplantation Program, Division of Medical Oncology and Hematology. Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Michelis FV; Department of Medicine, Section of Medical Oncology and Hematology, University of Toronto, Toronto, ON, Canada.; Hans Messner Allogeneic Blood and Marrow Transplantation Program, Division of Medical Oncology and Hematology. Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Lipton JH; Department of Medicine, Section of Medical Oncology and Hematology, University of Toronto, Toronto, ON, Canada.; Hans Messner Allogeneic Blood and Marrow Transplantation Program, Division of Medical Oncology and Hematology. Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Mattsson J; Department of Medicine, Section of Medical Oncology and Hematology, University of Toronto, Toronto, ON, Canada.; Hans Messner Allogeneic Blood and Marrow Transplantation Program, Division of Medical Oncology and Hematology. Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Alibhai SMH; Department of Medicine, University Health Network, Toronto, ON, Canada., Kumar R; Department of Medicine, Section of Medical Oncology and Hematology, University of Toronto, Toronto, ON, Canada. rajat.kumar@uhn.ca.; Hans Messner Allogeneic Blood and Marrow Transplantation Program, Division of Medical Oncology and Hematology. Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada. rajat.kumar@uhn.ca.

Publikováno v: Bone marrow transplantation [Bone Marrow Transplant] 2023 Nov; Vol. 58 (11), pp. 1237-1246. Date of Electronic Publication: 2023 Aug 24.

Single cord blood transplantation for acute myeloid leukemia patients aged 60 years or older: a retrospective study in Japan.

Autor: Isobe, Masamichi, Konuma, Takaaki, Masuko, Masayoshi, Uchida, Naoyuki, Miyakoshi, Shigesaburo, Sugio, Yasuhiro, Yoshida, Shuro, Tanaka, Masatsugu, Matsuhashi, Yoshiko, Hattori, Norimichi, Onizuka, Makoto, Aotsuka, Nobuyuki, Kouzai, Yasushi, Wake, Atsushi, Kimura, Takafumi, Ichinohe, Tatsuo, Atsuta, Yoshiko, Yanada, Masamitsu

Publikováno v: Annals of Hematology; Jul2021, Vol. 100 Issue 7, p1849-1861, 13p